Intima Bioscience

Intima Bioscience is a clinical-stage gene and cell therapy company focused on cancer treatments for solid tumors, combining patients' own immune cells with immune checkpoint targeting to treat solid tumors. Intima Bioscience is currently conducting Phase 1/2 clinical trials of its checkpoint cell therapy targeting the immune checkpoint CISH for gastrointestinal and colon cancer patients.